Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metacavir in Chronic Hepatitis B
NCT02965859Phase 2Unknown
- Sponsor
- ApicHope Pharmaceutical Group
- Start
- Dec 2012
- Primary completion
- Dec 2018
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of metacavir in Chronic Hepatitis B (CHB), sponsored by ApicHope Pharmaceutical Group. Status: unknown.
02
Drugs
metacavir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT02965859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02965859.